Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Emergent BioSolutions Inc (NYSE:EBS)

43.70
Delayed Data
As of May 27
 +0.55 / +1.27%
Today’s Change
27.68
Today|||52-Week Range
43.70
+9.22%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2012

2013

2014

2015
AssetsCash141.7M179.3M280.5M312.8M
 
 
 
 
 
Short Term Investment Cash-2.2M37.7M101.2M32.3M
 
 
 
 
 
Cash & Short Term Investments141.7M179.3M280.5M312.8M
 
 
 
 
 
 
ReceivablesReceivables96.0M66.2M60.2M127.3M
 
 
 
 
 
 
InventoriesInventories15.2M14.6M65.7M76.9M
 
 
 
 
 
 
Current AssetsOther Current Assets10.5M12.9M25.8M21.5M
 
 
 
 
 
Current Assets263.3M273.1M432.2M538.6M
 
 
 
 
 
 
Total AssetsProperty, Plant and Equipment - Gross284.7M321.6M393.4M431.4M
 
 
 
 
 
Depreciation-42.9M-57.4M-79.4M-99.5M
 
 
 
 
 
Intangible Assets47.3M85.9M178.1M154.8M
 
 
 
 
 
Other Assets48.0M89.3M186.3M161.8M
 
 
 
 
 
Total Assets564.2M626.6M945.3M1.0B
 
 
 
 
 
 
LiabilitiesAccounts Payable31.3M27.5M40.9M46.0M
 
 
 
 
 
Short Term Debt4.5M0.000.000.00
 
 
Accrued Expenses1.5M1.3M6.3M6.2M
 
 
 
 
 
Other Current Liabilities3.3M4.4M20.4M19.0M
 
 
 
 
 
Other Liabilities61.9M56.7M92.9M99.6M
 
 
 
 
 
 
Total LiabilitiesLong Term Debt58.3M62.0M251.0M253.0M
 
 
 
 
 
Deferred Taxes-11.1M0.00-12.8M-11.3M
 
 
 
 
Other Liabilities1.9M3.5M1.2M1.3M
 
 
 
 
 
Total Liabilities122.1M137.5M392.1M383.6M
 
 
 
 
 
 
EquityMinority Interest-5.4M-876.0K0.000.00
 
 
 
Preferred Stock0.000.000.000.00--
Common Equity441.4M489.6M553.2M660.0M
 
 
 
 
 
Total Shareholder Equity441.4M489.6M553.2M660.0M
 
 
 
 
 
 
Share InformationCommon Shares Outstanding35.9M36.6M37.7M39.4M
 
 
 
 
 
 
Addtl. Info.No data currently available for this section.